Latest News
Dr. Tamar Taddei on Yale Cancer Answers
- April 26, 2024
After receiving a diagnosis of a large gastric tumor and giant hiatal hernia, 83-year-old Rosa Chipelo needed surgery. Given her age and the complexity of the surgery, Mrs. Chipelo and her daughter Rosa had a big decision to make and they were desperately ready to find a surgeon they trusted. Mrs. Chipelo's Medical Oncologist Victor Chang, MD, at Smilow Cancer Hospital at Waterbury, partnered with Kiran Turaga, MD, MPH, Division Chief of Surgical Oncology at Smilow Cancer Hospital as his surgical counterpart. At the consultation with Dr. Turaga–who is a tall man–upon entering the room, Rosa explained, “He had us at ‘hello.’”
- April 26, 2024
On April 25, 2024, members of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center presented the third of four Gastrointestinal Cancer CME Series focused on Supportive Oncology Care for Gastrointestinal Cancers.
- April 25, 2024Source: Yale News
Inhibiting a certain protein in mice reduced obesity-induced liver tumor development, Yale researchers found. It could reveal a future treatment route.
- April 25, 2024
Each year, the academy — an honorary society and independent policy organization with initiatives in the arts, democracy, education, global affairs, and science — elects new members in recognition of their notable achievements in academia, industry, policy, research, and science..
- April 24, 2024
Yale School of Medicine and Equitable Breakthroughs in Medicine Development (EQBMED) — a multi-institute collaboration focused on clinical trial diversity — announced today a new partnership with 14 community and faith-based organizations and professional societies, furthering its mission to foster equitable access to clinical trials.
- April 24, 2024Source: MedScape
Remember to Make That Difference With Each Patient.
- April 24, 2024Source: YaleNews
Dr. Susan Baserga elected to American Academy of Arts and Sciences along with six other Yale Scholars.
- April 23, 2024
Yale scientists are working on an alternative treatment for COVID-19, for use in patients whose immune therapies clash with Paxlovid.
- April 23, 2024Source: LiveScience
A blood test like this would need to go through "extensive clinical trials" with thousands of patients and regulatory review, Dr. Michael Cecchini, co-director of the colorectal program at the Center for Gastrointestinal Cancers at the Yale Cancer Center who was not involved in the research, told Live Science.